MedQuist (MEDH -6.8%) takes a hit this morning on a Lazard downgrade to neutral from buy, The...

|By:, SA News Editor

MedQuist (MEDH -6.8%) takes a hit this morning on a Lazard downgrade to neutral from buy, The firm notes significant changes made to the company's strategic plan that have yet to be articulated.